M33.11 identifies adult-onset or non-juvenile dermatomyositis (classified as 'other' dermatomyositis within category M33.1) that is explicitly complicated by respiratory system involvement, such as interstitial lung disease or inflammatory pulmonary manifestations.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 0
- Region
- General
Documentation tips
What should appear in the chart to support M33.11.
Source · Editorial brief grounded in 5 cited references ↓
- Document that the dermatomyositis is adult-onset or non-juvenile to distinguish M33.1x from M33.0x (juvenile) — the treating physician must specify this or it must be inferable from the record.
- Explicitly name the respiratory complication (e.g., interstitial lung disease, organizing pneumonia, restrictive lung disease) and link it causally to the dermatomyositis diagnosis in the clinical note.
- Record pulmonary function test results, HRCT findings, or bronchoscopy findings that substantiate the respiratory involvement — this supports medical necessity and audit defense.
- If myopathy is also present, document whether the respiratory involvement or the myopathy is the primary focus of the current encounter; this guides selection between M33.11 and M33.12.
- Note disease onset age and classification basis (e.g., skin biopsy, EMG, muscle enzyme levels, autoantibody panel) to confirm 'other dermatomyositis' rather than juvenile or polymyositis subtypes.
Common coding pitfalls
The recurring mistakes coders make with M33.11 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M33.10 (organ involvement unspecified) when respiratory involvement is clearly documented in the record — M33.11 is required whenever the lung manifestation is specified.
- Confusing M33.11 (other/adult dermatomyositis with respiratory involvement) with M33.01 (juvenile dermatomyositis with respiratory involvement) — patient age and clinical classification must distinguish these.
- Failing to add a secondary code for the specific pulmonary manifestation (e.g., J84.10 for pulmonary fibrosis) when it is separately documented and managed.
- Assigning M33.11 for a patient whose pulmonary condition is incidental and not attributed by the clinician to the dermatomyositis — causal linkage must be documented, not assumed.
- Using M33.91 (dermatopolymyositis, unspecified, with respiratory involvement) when the type is not truly unspecified — if clinical documentation supports 'other dermatomyositis,' M33.11 is the correct, more specific code.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M33.11 sits under parent code M33.1 (Other dermatomyositis), which captures dermatomyositis that is not juvenile-onset (M33.0) and not otherwise unspecified (M33.9). Use M33.11 specifically when the medical record documents both the dermatomyositis diagnosis and a clinician-confirmed respiratory complication — most commonly interstitial lung disease (ILD), organizing pneumonia, or aspiration pneumonia secondary to pharyngeal muscle weakness. The respiratory involvement must be documented as a manifestation or complication of the dermatomyositis, not an incidental, unrelated pulmonary condition.
Within M33.1, the fifth-character options are: M33.10 (organ involvement unspecified), M33.11 (respiratory involvement), M33.12 (with myopathy), M33.13 (without myopathy), and M33.19 (other organ involvement). If a patient has both respiratory involvement and myopathy, assign the code that reflects the primary clinical focus documented by the treating physician, or query the provider about which manifestation is the principal reason for the encounter. Do not default to M33.10 when respiratory involvement is clearly documented — that constitutes undercoding.
Additional codes may be required for specific respiratory manifestations. For example, if interstitial pulmonary fibrosis is documented, assign J84.10 (Pulmonary fibrosis, unspecified) as a secondary code. CMS has explicitly listed M33.11 among ICD-10-CM codes that do not support medical necessity for amniotic/placental-derived product injections (LCD A59764), so be aware of payer-specific coverage implications when this code appears on claims for musculoskeletal injection procedures.
Sibling codes
Other billable codes under M33.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What distinguishes M33.11 from M33.01?
02Should I code M33.11 and M33.12 together if a patient has both respiratory involvement and myopathy?
03Can I add a separate respiratory diagnosis code alongside M33.11?
04Is M33.11 valid for inpatient hospital coding?
05What documentation is needed to avoid downcoding to M33.10?
06Does M33.11 affect coverage for musculoskeletal injection procedures?
07When should I use M33.19 instead of M33.11?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M33-/M33.11
- 03outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/code-dermatomyositis-common-rheumatology-disorder/
- 04cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=59764&ver=13
- 05vsac.nlm.nih.govhttps://vsac.nlm.nih.gov/context/cs/codesystem/ICD10CM/version/2023/code/M33.11/info
Mira AI Scribe
Mira's AI scribe captures the treating clinician's explicit linkage between the dermatomyositis subtype (adult/non-juvenile) and the respiratory complication — including pulmonary function test values, HRCT findings, and the clinical judgment connecting lung disease to the inflammatory myopathy. That captured context prevents downcoding to M33.10 (unspecified organ involvement) and supports medical necessity documentation for pulmonary subspecialty co-management claims.
See how Mira captures M33.11 documentation